Antiproliferative effects of DNA methyltransferase 3B depletion are not associated with DNA demethylation.

PloS One
Sabine HagemannAnette Sommer

Abstract

Silencing of genes by hypermethylation contributes to cancer progression and has been shown to occur with increased frequency at specific genomic loci. However, the precise mechanisms underlying the establishment and maintenance of aberrant methylation marks are still elusive. The de novo DNA methyltransferase 3B (DNMT3B) has been suggested to play an important role in the generation of cancer-specific methylation patterns. Previous studies have shown that a reduction of DNMT3B protein levels induces antiproliferative effects in cancer cells that were attributed to the demethylation and reactivation of tumor suppressor genes. However, methylation changes have not been analyzed in detail yet. Using RNA interference we reduced DNMT3B protein levels in colon cancer cell lines. Our results confirm that depletion of DNMT3B specifically reduced the proliferation rate of DNMT3B-overexpressing colon cancer cell lines. However, genome-scale DNA methylation profiling failed to reveal methylation changes at putative DNMT3B target genes, even in the complete absence of DNMT3B. These results show that DNMT3B is dispensable for the maintenance of aberrant DNA methylation patterns in human colon cancer cells and they have important implicatio...Continue Reading

Associated Datasets

References

Apr 21, 1995·Cell·P W LairdR Jaenisch
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Apr 5, 2002·Nature·Ina RheeBert Vogelstein
May 17, 2002·The Journal of Biological Chemistry·Normand BeaulieuA Robert MacLeod
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Mar 3, 2005·Chembiochem : a European Journal of Chemical Biology·Ursula EgnerMartin Schneider
Jun 15, 2005·Annual Review of Biochemistry·Mary Grace Goll, Timothy H Bestor
Apr 4, 2006·Molecular and Cellular Biology·Haijiang LinRudolf Jaenisch
Sep 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Gerda EggerGangning Liang
Oct 4, 2006·Molecular and Cellular Biology·Alexander UnterbergerMoshe Szyf
Jan 4, 2007·Nature Genetics·Martin WidschwendterPeter W Laird
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
May 13, 2008·Cancer Letters·Jens M TeodoridisRobert Brown
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Katsuhiko NoshoShuji Ogino
Feb 6, 2010·Genome Research·Louise LaurentChia-Lin Wei
Sep 16, 2010·Nucleic Acids Research·Si Ho ChoiAllen S Yang
Apr 13, 2011·Genes, Chromosomes & Cancer·Laia Simó-RiudalbasManel Esteller
Apr 15, 2011·The Journal of Clinical Investigation·Eveline J SteineHeinz G Linhart
Aug 16, 2011·Genomics·Marina BibikovaRichard Shen
Oct 1, 2009·Epigenomics·Marina BibikovaKevin L Gunderson
Dec 3, 2011·The Journal of Clinical Investigation·Ryan A HladyRene Opavsky

❮ Previous
Next ❯

Citations

Dec 19, 2014·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Alessio PerottiAnnamaria Buschini
Jul 10, 2021·The Journal of Nutritional Biochemistry·Megan BeetchBarbara Stefanska
May 22, 2020·ACS Medicinal Chemistry Letters·Ana S NewtonWilliam L Jorgensen

❮ Previous
Next ❯

Datasets Mentioned

BETA
E-MTAB-719

Methods Mentioned

BETA
transgenic
FCS
PCR
ELISA
transfection
chip

Software Mentioned

CellQuest Pro
BeadStudio
R stats package
ImageJ
Illumina

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.